Cadrenal Therapeutics (CVKD)

• Market cap: $27M
• 1 day: 2.24%
• 5 days: -5.1%
• 1 month: 1.15%
• 3 months: 22.43%
• 6 months: -18.36%
• Year to date: -14.77%
• 1 year: -13.32%
• 5 years: -78.62%
• 10 years: -78.62%
• Sector: Healthcare
• Industry: Biotechnology

About: Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Employees: 4